Source: Annual Congress 2008 - Wider aspects of managing respiratory disease in primary care
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
R. Arnou, G. Icardi, M. De Decker, A. Ambrozaitis, P. Eavis, J. R. De Juanes Pardo, M. P. Kazek, A. Hoffenbach (Angers, Lyon, France; Genova, Italy; Antwerp, Belgium; Vilnius, Lithuania; Bath, United Kingdom; Madrid, Spain). Novel intradermal influenza vaccine: phase 3 data in targeted adult populations. Eur Respir J 2008; 32: Suppl. 52, 223

Member's Comments

No comment yet.

Related content which might interest you: A randomized, open-label, parallel design study to compare the immunogenicity of simultaneous administration versus sequential administration of quadrivalent influenza vaccine and 23-valent pneumococcal polysaccharide vaccine in the elderly Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis   Year: 2017 Development of RSV vaccines: where are we? Source: International Congress 2019 – Respiratory syncytial virus infections throughout life Year: 2019 Additive preventive effect of influenza and pneumococcal vaccines in elderly persons Source: Eur Respir J 2004; 23: 363-368 Year: 2004 Prime-boost, double-dose immunization and immunity to influenza vaccination in COPD Source: Virtual Congress 2021 – Pneumonia Year: 2021 Influenza: vaccination and treatment Source: Eur Respir J 2001; 17: 1282-1293 Year: 2001 Immunogenicity and safety of a novel recombinant pandemic influenza vaccine containing a polysaccharide adjuvant Source: Annual Congress 2010 - Influenza A (H1N1) and other viral infections: therapeutic aspects Year: 2010 Safety and immunogenicity of a dose-sparing, trivalent inactivated seasonal influenza vaccine containing an advax adjuvant – a phase 1/2 randomised controlled trial Source: Annual Congress 2008 - Community-acquired pneumonia: prognosis, complications and prevention Year: 2008 Pneumococcal and influenza vaccination Source: Respipedia Article Year: 2018 Efficacy of two different vaccination schemes for influenza annual vaccination in cystic fibrosis patients 3-8-years-old Source: Eur Respir J 2001; 18: Suppl. 33, 539s Year: 2001 Monitoring the kinetics of a vaccine-induced T-cell response after H1N1 influenza vaccination Source: Annual Congress 2010 - Influenza A (H1N1) and other viral infections: therapeutic aspects Year: 2010 Practicalities of human inoculation to establish experimental pneumococcal carriage in vaccine studies Source: Annual Congress 2010 - Mechanisms of respiratory infections Year: 2010 Influenza and pneumococcal immunization initiates work Source: Eur Respir J 2001; 18: Suppl. 33, 207s Year: 2001 Searching for a pandemic influenza vaccine Source: International Congress 2014 – Virulent topics in respiratory infections Year: 2014 New treatments for RSV and other viruses, including update on vaccines Source: ERS Courses: Paediatric respiratory infections Year: 2019 Impact of influenza vaccination in patients with CAP Source: Annual Congress 2009 - Aetiology and treatment of community-acquired pneumonia Year: 2009 The relation of people to vaccination against an influenza virus Source: Annual Congress 2010 - Influenza A (H1N1) and other viral infections: therapeutic aspects Year: 2010 Antibody response to influenza vaccine in patients with sarcoidosis Source: Annual Congress 2010 - Asthma: clinical aspects and treatment Year: 2010